Evidence map›Paper›PMID 32016535›Full record

ReviewIntensive care medicine2020

Management of HIV-infected patients in the intensive care unit.

François Barbier, Mervin Mer, Piotr Szychowiak, Robert F Miller, Éric Mariotte, Lionel Galicier, Lila Bouadma, Pierre Tattevin, Élie Azoulay

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in Intensive care medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06145841 (Clinical Application of Metagenomic Next-Generation Sequencing-Guided Anti-Infection Strategies in AIDS Patients With Severe Pneumonia and/or Sepsis), which is not on this map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06145841 recruitingnot on this mapstarted 2023, after this paper: background citation

Clinical Application of Metagenomic Next-Generation Sequencing-Guided Anti-Infection Strategies in AIDS Patients With Severe Pneumonia and/or Sepsis

TypeobservationalSponsorGuangzhou 8th People's HospitalRan2023 to 2027Enrolled400ConditionsAIDS, Pneumonia, Sepsis, NeonatalArmsPathogen metagenomic next-generation sequencing
3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Review
  3. HIV disease in the ICU: an evolving challenge.Proceedings (Baylor University. Medical Center) · 2026
    Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Guidelines for Antibiotics Prescription in Critically Ill Patients.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2024
    Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 4 countries.

François BarbierMedical Intensive Care Unit, La Source Hospital, CHR Orléans, Orléans, France. francois.barbier@chr-orleans.fr.ORCID 0000-0002-8447-7265
Mervin MerFaculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Piotr SzychowiakMedical Intensive Care Unit, La Source Hospital, CHR Orléans, Orléans, France.
Robert F MillerResearch Department of Infection and Population Health, University College London, London, UK.
Éric MariotteMedical Intensive Care Unit, Saint-Louis University Hospital, APHP, Paris, France.
Lionel GalicierDepartment of Clinical Immunology, Saint-Louis University Hospital, APHP, Paris, France.
Lila BouadmaMedical and Infectious Diseases Intensive Care Unit, Bichat-Claude Bernard University Hospital, APHP, Paris, France.
Pierre TattevinInfectious Diseases and Medical Intensive Care Unit, Pontchaillou University Hospital, Rennes, France.
Élie AzoulayMedical Intensive Care Unit, Saint-Louis University Hospital, APHP, Paris, France. elie.azoulay@aphp.fr.
Assistance Publique – Hôpitaux de Paris · FRCentre hospitalier universitaire d'Orléans · FRHôpital Pontchaillou · FRInserm · FRUniversité Claude Bernard Lyon 1 · FRUniversity College London · GBUniversity of the Witwatersrand · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The widespread use of combination antiretroviral therapies (cART) has converted the prognosis of HIV infection from a rapidly progressive and ultimately fatal disease to a chronic condition with limited impact on life expectancy. Yet, HIV-infected patients remain at high risk for critical illness due to the occurrence of severe opportunistic infections in those with advanced immunosuppression (i.e., inaugural admissions or limited access to cART), a pronounced susceptibility to bacterial sepsis and tuberculosis at every stage of HIV infection, and a rising prevalence of underlying comorbidities such as chronic obstructive pulmonary diseases, atherosclerosis or non-AIDS-defining neoplasms in cART-treated patients aging with controlled viral replication. Several patterns of intensive care have markedly evolved in this patient population over the late cART era, including a steady decline in AIDS-related admissions, an opposite trend in admissions for exacerbated comorbidities, the emergence of additional drivers of immunosuppression (e.g., anti-neoplastic chemotherapy or solid organ transplantation), the management of cART in the acute phase of critical illness, and a dramatic progress in short-term survival that mainly results from general advances in intensive care practices. Besides, there is a lack of data regarding other features of ICU and post-ICU care in these patients, especially on the impact of sociological factors on clinical presentation and prognosis, the optimal timing of cART introduction in AIDS-related admissions, determinants of end-of-life decisions, long-term survival, and functional outcomes. In this narrative review, we sought to depict the current evidence regarding the management of HIV-infected patients admitted to the intensive care unit.

Indexed as

Anti-Retroviral AgentsCritical IllnessCytomegalovirus InfectionsDisease ManagementHIV InfectionsHumansIntensive Care UnitsLong Term Adverse EffectsPrevalenceRespiratory InsufficiencyRisk FactorsAnti-Retroviral AgentsAcquired immunodeficiency syndromeAntiretroviral therapyBacterial sepsisIntensive care unitMechanical ventilationOutcomePneumocystis jirovecii pneumonia

Identifiers

PMID32016535
PMCPMC7095039
OpenAlexW3003414838

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.